Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $40 | $89 | $46 | $64 |
| Short-Term Investments | $35 | $12 | $134 | $159 |
| Receivables | $14 | $1 | $2 | $10 |
| Inventory | $9 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $4 | $10 |
| Total Curr. Assets | $101 | $104 | $187 | $244 |
| Property Plant & Equip (Net) | $2 | $3 | $6 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $6 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$6 | $5 | $4 | $4 |
| Total NC Assets | $2 | $8 | $10 | $19 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $103 | $112 | $197 | $263 |
| Liabilities | – | – | – | – |
| Payables | $38 | $41 | $44 | $54 |
| Short-Term Debt | $1 | $1 | $2 | $2 |
| Tax Payable | $3 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $11 | $8 | $6 |
| Total Curr. Liab. | $43 | $53 | $53 | $62 |
| LT Debt | $29 | $0 | $0 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $11 | $9 | $9 |
| Total NC Liab. | $33 | $11 | $9 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $75 | $64 | $63 | $73 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,119 | -$1,044 | -$885 | -$724 |
| AOCI | -$3 | -$3 | -$2 | -$3 |
| Other Equity | $1,150 | $1,094 | $1,021 | $918 |
| Total Equity | $28 | $48 | $134 | $190 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $103 | $112 | $197 | $263 |
| Net Debt | -$11 | -$87 | -$44 | -$60 |